HCPCS Codes Similar to G9280

HCPCS Codes Similar to “G9280” Code.
Pneumococcal vaccination not administered prior to discharge, reason not specified

G9279 Pneumococcal screening performed and documentation of vaccination received prior to discharge Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON
M0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON	Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON
Q0221 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg Code added date: 20220224 Code effective date: 20241213 TXT \| PDF \| XML \| JSON	Q0224 Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg Code added date: 20240322 Code effective date: 20240322 TXT \| PDF \| XML \| JSON
G2156 Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON	G2155 Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) Code added date: 20200101 Code effective date: 20210101 TXT \| PDF \| XML \| JSON
G9281 Screening performed and documentation that vaccination not indicated/patient refusal Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	M1417 Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1418 Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1419 Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1468 Patient received recommended doses of hepatitis b vaccination based on age Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON	M1471 Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON